- Home
- Automated
- List of product information
- MUCOSOLVAN 24 HOURS CAPSULE 75MG [SIN13373P]
MUCOSOLVAN 24 HOURS CAPSULE 75MG [SIN13373P]
Active ingredients: MUCOSOLVAN 24 HOURS CAPSULE 75MG
On this page
Product Info
MUCOSOLVAN 24 HOURS CAPSULE 75MG
[SIN13373P]
Product information
Active Ingredient and Strength | AMBROXOL HYDROCHLORIDE - 75 MG |
Dosage Form | CAPSULE, DELAYED RELEASE |
Manufacturer and Country | SANOFI WINTHROP INDUSTRIE - FRANCE |
Registration Number | SIN13373P |
Licence Holder | OPELLA HEALTHCARE SINGAPORE PTE. LTD. |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | R05CB06 |
(b) What MUCOSOLVAN once-daily prolonged-release capsules are and what they are used for
Mucosolvan is used in conditions where there are a lot of thick secretion or mucus in your air passages.
Mucosolvan contains ambroxol hydrochloride, which helps to clear the chest by thinning the mucus in your air passage.
(d) How to take MUCOSOLVAN once-daily prolonged-release capsules
Always take this medicine exactly as described in this package leaflet or exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is: The usual dosage is one prolonged-release capsule (equivalent to 75 mg ambroxol hydrochloride/day) once daily.
Method and duration of treatment
MUCOSOLVAN once-daily prolonged-release capsules can be taken with or without food and should be swallowed whole with sufficient amounts of liquid (e.g., water, tea or fruit juice).
You should consult a doctor if your symptoms worsen or if there is no improvement after 4–5 days.
Please speak to your doctor or pharmacist if you feel that the effect of MUCOSOLVAN once-daily prolonged-release capsules is too strong or too weak.
(c) What you need to know before you take MUCOSOLVAN once-daily prolonged-release capsules
MUCOSOLVAN once-daily prolonged-release capsules should not be taken:
If you are hypersensitive (allergic) to the active substance ambroxol hydrochloride or to any of the other ingredients of this medicine listed in Section (a) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
